OBJECTIVE: To observe the clinical efficacy and safety of Yiqi Yangxue formula (YQYXF) on knee osteoarthritis (KOA), and to explore the underlying therapeutic mechanism of YQYXF through endogenous differential metabolites and their related metabolic pathways.
We developed a urinary exosome isolation kit (EVLatch), which enables enrichment of exosomes from human urine with higher purity and yield than ultracentrifugation
